Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
LY3209590 for Type 2 Diabetes
Recruiting1 awardPhase 1
Atlanta, Georgia
This trial aims to see how a drug called LY3209590 is absorbed and removed from the body in children with Type 2 Diabetes. The study will take around 100 days to complete.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.